Jason Lettmann's Net Worth

$279 Thousand

Estimate Recalculated Sep 8, 2024 07:19PM EST

Who is Jason Lettmann?

Jason Lettmann does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALX ONCOLOGY HOLDINGS INC, and Ra Pharmaceuticals, Inc..

SEC CIK

Jason Lettmann's CIK is 0001688269

Past Insider Trading and Trends

2024 was Jason Lettmann's most active year for acquiring shares with 3 total transactions. Jason Lettmann's most active month to acquire stocks was the month of May. 2020 was Jason Lettmann's most active year for disposing of shares, totalling 2 transactions. Jason Lettmann's most active month to dispose stocks was the month of June. 2024 saw Jason Lettmann paying a total of $49,771.48 for 254,400 shares, this is the most they've acquired in one year. In 2024 Jason Lettmann cashed out on 2,191 shares for a total of $5,652.78, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $1.91

CHIEF EXECUTIVE OFFICER

Jason Lettmann owns 169,429 units of Common Stock which is worth $323,609.39. From 2020 to 2024 Jason Lettmann acquired a total of 153,104 shares in ALX ONCOLOGY HOLDINGS INC at a cost of $49,771.48, Jason also disposed a total of 2,191 shares of ALX ONCOLOGY HOLDINGS INC equalling to $5,652.78.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.28%
-2.19K
$2.58
-$5,652.78
169.43K
Aug 14
Form 4
+2.63%
4.4K
$11.31
$49,771.48
171.62K
Mar 14
Form 4
+55.96%
60K
—
—
167.22K
Feb 14
Form 4
—
0
—
—
0
Sep 8
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 15
Form 4
-2.22%
-325.38K
$27.91
-$8,901,803.95
14.36M
Dec 13
Form 4
-0.73%
-145.64K
$32.17
-$4,698,091.14
19.84M
Dec 8 - Dec 10
Form 4
—
0
—
—
0
Jun 11
Form 4
+398.72%
4.18M
$19.00
$7,600,000.00
5.23M
Jul 21
Form 4
—
0
—
—
0
Jul 16
Form 3
—
0
—
—
0
No matching records found

Ra Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
+23,622.45%
4.05M
$12.11
-$4,420.00
4.07M
Oct 31
Form 3
—
0
—
—
0
No matching records found